Pharmacogenomics and Precision Medicine is trending like never before, with the strides that are being made in this field. While you can go and search out the news yourself, we want to make it easy for you. You can start by following social media platforms: YouScript Facebook, YouScript Twitter, Pinterest, LinkedIn, and our partner sites Genelex Facebook and Genelex Twitter. … Read More
Updated Phenotype Terminology
YouScript and Genelex Labs have updated their phenotype names to be consistent with the standardized terms for clinical pharmacogenetic test results proposed by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in the July 2016 issue of Genetics in Medicine. Like CPIC, we believe that implementing standardized terminology is an important step toward the widespread adoption of clinical pharmacogenetics. These standard terms … Read More
CYP2D6 Testing Could Ease Parents Fears After Codeine Warning
A recent warning from the American Academy of Pediatrics has many parents worrying if their child is an ultrarapid metabolizer of the popular drug codeine. The clinical report is calling for a formal restriction of codeine, over risks of life-threatening or fatal breathing reactions. The pain reliever is often given in hospitals for procedures such as tonsillectomies and is commonly … Read More
This Month in Pharmacogenetics
We’re back again with another round of PGx Articles. Pharmacogenomics is on the rise, and with the groundswell of support we’re seeing, it’s only a matter of time before we see more widespread support and implementation. Want to be ahead of the curve? Want to be that person who says “remember when I told you about pharmacogenetics years ago” to … Read More
Is Big Data Clinically Significant?
A restaurant patron doesn’t leave a tip as he storms out of the trashy diner that Google “recommended” to him. This is an example of big data trying to predict what kind of restaurants that customer might enjoy, and missing the mark entirely. Nevertheless, the consequences of this blunder are mild, maybe resulting in an upset stomach or a dented … Read More
Recent Article in JAMA Underscores Need for Pharmacogenetics
On March 21, an article published online in JAMA Internal Medicine examined changes in the prevalence of medication use and the frequency of major drug-drug interactions. The study was authored by Dima M. Qato, PharmD, MPH, PhD of the Department of Pharmacy Systems, Outcomes, and Policy at the University of Illinois at Chicago, and colleagues. In-home interviews, with direct medication … Read More
U.S. VA Awards Genelex Contract to Reduce Veterans’ Healthcare Costs
The U.S. Department of Veterans Affairs has awarded a Federal Supply Schedule contract to Genelex as a government supplier, which took effect March 15th, 2016. The contract makes pharmacogenetic testing accessible to clinicians in the Veterans Administration, so their patients can immediately benefit from precision medicine. The approval will also allow healthcare providers in the Department of Defense, Bureau of … Read More
Genelex receives Innovative Technology Designation from Vizient, Inc. for YouScript®
Designation recognizes the development of new solutions that benefit the health care industry Seattle, WA; January 27, 2015 – Genelex announced its YouScript® Precision Prescribing analytics software has received Innovative Technology designation from Vizient, Inc., formerly Novation, the largest member-owned health care company in the country. The designation was based on reviews of YouScript by hospital experts who attended Vizient’s … Read More
Time to rethink long-term use of common heart medications?
Is it time to reconsider long-term use of four large classes of cardiovascular drugs? In a review article recently published in the Journal of the American College of Cardiology, the authors address this very question. The authors focus their review on the “big four” types of medications used (often in combination) to treat coronary heart disease: aspirin, beta-blockers, statins and … Read More
Genelex COO to speak at 7th annual precision medicine conference
Genelex COO Kristine Ashcraft will be one of dozens of speakers at the seventh annual Personalized and Precision Medicine Conference, an official satellite event of the American Society of Human Genetics, in Baltimore this October. Ashcraft will discuss studies and pilots showing financial and clinical improvements that get the attention of busy risk managers and how precision medicine and pharmacogenetic … Read More